MARCHETTI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 1.412
AS - Asia 719
EU - Europa 604
SA - Sud America 126
AF - Africa 9
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.873
Nazione #
US - Stati Uniti d'America 1.379
SG - Singapore 397
IE - Irlanda 224
CN - Cina 116
BR - Brasile 113
DE - Germania 89
RU - Federazione Russa 73
HK - Hong Kong 66
UA - Ucraina 53
VN - Vietnam 52
TR - Turchia 34
SE - Svezia 29
IT - Italia 28
FI - Finlandia 20
GB - Regno Unito 20
CA - Canada 18
CZ - Repubblica Ceca 18
BE - Belgio 17
JP - Giappone 12
MX - Messico 12
FR - Francia 10
IN - India 9
IQ - Iraq 8
PL - Polonia 8
BD - Bangladesh 7
AR - Argentina 5
JO - Giordania 5
ZA - Sudafrica 5
ES - Italia 4
EC - Ecuador 3
LT - Lituania 3
NL - Olanda 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
HN - Honduras 2
KZ - Kazakistan 2
MA - Marocco 2
PK - Pakistan 2
AU - Australia 1
BH - Bahrain 1
BY - Bielorussia 1
EG - Egitto 1
EU - Europa 1
ID - Indonesia 1
IL - Israele 1
LY - Libia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 2.873
Città #
Dublin 224
Chandler 208
Dallas 203
Singapore 202
Jacksonville 173
Ashburn 84
New York 70
Hong Kong 66
Santa Clara 64
Ann Arbor 53
Boardman 48
Beijing 37
Munich 32
Lawrence 29
Princeton 29
Izmir 23
Los Angeles 23
The Dalles 20
Wilmington 20
Brno 18
Brussels 17
São Paulo 14
Bremen 12
Dong Ket 12
Helsinki 12
Ho Chi Minh City 12
Moscow 12
Tokyo 12
Columbus 10
Dearborn 10
Seattle 10
Assago 8
Montreal 8
San Mateo 8
Falkenstein 7
Hanoi 7
Mexico City 7
Nanchang 7
Stockholm 7
Brooklyn 6
Council Bluffs 6
Denver 6
Haiphong 6
Houston 6
London 6
Nanjing 6
San Jose 6
Amman 5
Atlanta 5
Johannesburg 5
Orem 5
San Francisco 5
Shanghai 5
Warsaw 5
Woodbridge 5
Ankara 4
Baghdad 4
Campinas 4
Campo Grande 4
Chicago 4
Turku 4
Amsterdam 3
Belo Horizonte 3
Boston 3
Da Nang 3
Des Moines 3
Guangzhou 3
Ningbo 3
Nuremberg 3
Poplar 3
Rio de Janeiro 3
Rome 3
Taizhou 3
Tianjin 3
Toronto 3
Baotou 2
Cacoal 2
Chennai 2
Dhaka 2
Florence 2
Frankfurt am Main 2
Goiânia 2
Guayaquil 2
Hải Dương 2
Jiaxing 2
Lanzhou 2
Lappeenranta 2
Monte Grande 2
Mumbai 2
New Delhi 2
Ninh Bình 2
Norwalk 2
Paris 2
Phoenix 2
Pune 2
Volta Redonda 2
Wroclaw 2
Wuxi 2
Ahmedabad 1
Alegrete 1
Totale 2.020
Nome #
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 123
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 121
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index 120
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 116
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 116
Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study 112
Factors influencing the clinical presentation of breakthrough pain in cancer patients 110
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 110
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 109
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 105
Evaluation of prognostic factors for survival in transverse colon cancer 105
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 102
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 102
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 102
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice 98
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 98
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan 93
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 90
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 90
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 88
Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey 87
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer. 85
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 83
Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with nivolumab: The Italian NSCLC expanded access program 82
BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories 79
What cancer patients actually know regarding Medical Cannabis? A cross-sectional survey with a critical analysis of the current attitudes 79
Recidive loco-regionali da carcinoma colo-rettale: risultati a breve termine della perfusione pelvica ipossica. 78
Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results 71
Is it possible to teach pain therapy playing basketball? 58
Integration between oncology and palliative care: Does one size fit all? 58
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study 53
Totale 2.923
Categoria #
all - tutte 14.011
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.011


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 4 29 8 35 4 40 13
2021/2022110 3 3 7 5 11 0 2 11 10 3 16 39
2022/2023612 37 51 3 80 34 64 0 32 280 4 20 7
2023/2024185 13 12 4 12 15 78 0 7 0 7 7 30
2024/2025714 23 9 44 39 83 49 100 56 185 26 55 45
2025/2026824 86 133 165 168 182 90 0 0 0 0 0 0
Totale 2.923